Abstract from AroCell has been accepted for presentation in a Poster Session at the AACR Annual Meeting 2020

An abstract from AroCell has been accepted for poster presentation on the American Association of Cancer Research 2020 (AACR 2020) held April 24-29 in San Diego, California, USA.

The abstract is entitled “Evaluation of TK1 protein changes using the AroCell TK 210 ELISA in an acute myeloid leukemia (AML) xenograft model during 5-fluoruracil treatment.” by Jagarlamudi KK. The study describes the utility of TK1 protein levels by AroCell TK 210 ELISA to monitor the changes in AML xenograft mouse model during 5-fluorouracil treatment.

The abstract will be online on the AACR Online Itinerary on Tuesday, March 24, 2020.